IRIS UniCatt

Citterio, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.596
NA - Nord America 4.818
AS - Asia 1.798
SA - Sud America 373
AF - Africa 94
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 20.699
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.457
US - Stati Uniti d'America 4.745
DE - Germania 1.053
SG - Singapore 705
SE - Svezia 643
CN - Cina 586
NL - Olanda 547
UA - Ucraina 518
BR - Brasile 329
FR - Francia 300
IE - Irlanda 259
ID - Indonesia 155
PL - Polonia 155
GB - Regno Unito 150
FI - Finlandia 138
RU - Federazione Russa 114
IN - India 97
CH - Svizzera 61
TR - Turchia 54
CI - Costa d'Avorio 49
CA - Canada 48
BE - Belgio 46
ES - Italia 32
JP - Giappone 32
VN - Vietnam 28
IR - Iran 27
HK - Hong Kong 19
AT - Austria 15
CZ - Repubblica Ceca 15
MX - Messico 15
CO - Colombia 13
MA - Marocco 13
PK - Pakistan 11
RO - Romania 11
AL - Albania 10
AU - Australia 10
CL - Cile 10
BD - Bangladesh 9
BG - Bulgaria 9
IQ - Iraq 9
GR - Grecia 8
KR - Corea 8
TH - Thailandia 8
TW - Taiwan 8
ZA - Sudafrica 8
EG - Egitto 7
IL - Israele 7
LT - Lituania 7
AR - Argentina 6
HU - Ungheria 6
PH - Filippine 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
PT - Portogallo 5
VE - Venezuela 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EC - Ecuador 4
JM - Giamaica 4
NO - Norvegia 4
NP - Nepal 4
RS - Serbia 4
SA - Arabia Saudita 4
SI - Slovenia 4
SM - San Marino 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DK - Danimarca 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
MY - Malesia 3
PA - Panama 3
PY - Paraguay 3
A1 - Anonimo 2
CV - Capo Verde 2
EU - Europa 2
GE - Georgia 2
IS - Islanda 2
MT - Malta 2
NZ - Nuova Zelanda 2
PE - Perù 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
QA - Qatar 1
SD - Sudan 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 20.699
Salva come PNG Salva come JPEG
Città #
Chandler 1.028
Milan 993
Rome 695
Ashburn 384
Singapore 379
Naples 303
Jacksonville 247
San Mateo 246
Dublin 245
Turin 190
New York 163
Wilmington 162
Jakarta 151
Florence 144
Bologna 138
Nanjing 129
Ann Arbor 127
Palermo 122
Boston 112
Fairfield 111
Lawrence 94
Cattolica 93
Bari 92
Genoa 87
Catania 85
Warsaw 81
Dearborn 79
Beijing 78
Redwood City 67
Moscow 65
Verona 61
Houston 59
Brescia 54
Princeton 54
Seattle 52
Kraków 50
Abidjan 49
Nürnberg 49
Woodbridge 48
Padova 45
Los Angeles 41
Venice 40
Nanchang 39
Parma 39
Bergamo 36
Brussels 36
Guangzhou 36
Redmond 35
Mountain View 34
Taranto 34
Messina 33
Chicago 32
Frankfurt am Main 32
Perugia 31
São Paulo 31
Reggio Emilia 30
Boardman 29
Cagliari 29
Hangzhou 29
Lancaster 29
Pescara 28
Norwalk 27
Shenyang 27
University Park 27
Izmir 26
Munich 26
Augusta 25
Hebei 25
Livorno 25
Helsinki 23
Marseille 23
Salerno 23
Bremen 22
Lucca 22
Kunming 21
Modena 21
Toronto 21
Monza 20
Novara 20
Rimini 20
Trieste 20
Zhengzhou 20
Changsha 19
Hong Kong 18
Leawood 18
London 17
San Francisco 17
The Dalles 17
Hanoi 15
Jiaxing 15
Rio de Janeiro 15
Caserta 14
Santa Clara 14
Tianjin 14
Amsterdam 13
Andover 13
Cambridge 13
Cesano Maderno 13
Lecce 13
Nuremberg 13
Totale 8.869
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 10.059
Accidental transplantation of a kidney with stones: case report 161
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 152
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 144
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 135
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 132
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 131
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 131
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 130
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 128
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 127
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 122
Belatacept utilization recommendations: an expert position 121
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 120
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 117
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 108
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 106
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 104
Interventional radiological treatment of renal transplant complications: a pictorial review 103
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 102
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 102
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 100
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 100
Complete clinical remission of psoriasis 6 months after renal transplantation 99
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 97
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 97
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 96
Significant improvement in patient survival after renal transplantation in the last decade. 95
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 95
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 94
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 94
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 94
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 93
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 92
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 91
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 90
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 90
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 89
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 89
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 86
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 85
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 84
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 84
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 83
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 82
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 82
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 81
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 81
Evolution of causes of mortality in renal transplantation in the last 10 years 80
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 80
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 79
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 78
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 78
Anonymity and live-donor transplantation: an ELPAT view 77
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 77
Belatacept utilization recommendations: an expert position 76
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 76
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 75
[Organ transplantation: training and prospects for a young surgeon] 74
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 74
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 73
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 73
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 71
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 71
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 71
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 70
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 70
Isoprinosine effects on postoperative immunodepression 69
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 69
Belatacept utilization recommendations: an expert position 69
Surgical Antibiotic Prophylaxis After Renal Transplantation: Time to Reconsider. 69
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 69
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 68
Re: Complete Clinical Remission of Psoriasis 6 Months After Renal Transplantation Response 68
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 68
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 68
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 67
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 67
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 66
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 66
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 66
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 66
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 65
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results 65
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 65
Anonymity and live-donor transplantation: an ELPAT view 64
Prediction, prevention, and management of delayed graft function: where are we now? 64
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 64
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 64
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 64
Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23 62
Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature 62
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 62
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study 61
Outcome of liver transplatation after acute rejection and sepsis 61
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 61
COVID-19 and kidney transplantation: an Italian Survey and Consensus 61
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 60
Recommendations on Anonymity in Living Kidney Donation: An ELPAT View 60
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial 60
Totale 18.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 0 0 0 0 0 0 0 145
2020/20211.146 71 125 29 125 157 100 125 31 152 33 176 22
2021/20221.336 84 125 27 52 46 55 37 227 49 98 267 269
2022/20233.797 332 348 192 452 177 432 152 343 495 203 385 286
2023/20244.961 284 576 300 374 340 488 402 417 349 444 487 500
2024/20256.760 492 664 689 565 691 508 517 589 823 439 662 121
Totale 20.830